Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2026 · third_quarter · Q3
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program.
Source: Senate LDA
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 In July, the National MS Society submitted comments on the Office of Management and Budgets (OMB) proposed Regulation for Federal Financial Assistance, expressing concern over impacts the rule may have on grant review and federal research investments.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act Continued to advocate on H.R.1 implementation. In July, the National MS Society commented on CMSs Medicaid Community Engagement Requirement centering around administrative barriers that could jeopardize health coverage for people living with MS and other chronic conditions, and urging CMS to maintain robust protections and exemptions to ensure uninterrupted access to care and treatment.
Accelerating Kids’ Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Credit for Caring Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Insurance Fraud Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Mobility Means Freedom Tax Credit Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Lifespan Respite Care Reauthorization Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Websites and Software Applications Accessibility Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Improving Seniors’ Timely Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
ENROLL Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
PBM Reform Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Telehealth Modernization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Seniors Deserve SMARTER Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
HEALTHY BRAINS Act of 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 In July, the National MS Society submitted comments on the Office of Management and Budgets (OMB) proposed Regulation for Federal Financial Assistance, expressing concern over impacts the rule may have on grant review and federal research investments.
Every Dollar Counts Act of 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 In July, the National MS Society submitted comments on the Office of Management and Budgets (OMB) proposed Regulation for Federal Financial Assistance, expressing concern over impacts the rule may have on grant review and federal research investments.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program.
Department of Defense Appropriations Act, 2027
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program.
Improving Seniors’ Timely Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
ENROLL Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Health Care Freedom for Patients Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
PBM FAIR Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Accelerating Kids’ Access to Care Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Lifespan Respite Care Reauthorization Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Credit for Caring Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Insurance Fraud Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Long COVID RECOVERY NOW Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Long COVID RECOVERY NOW Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage
Long COVID RECOVERY NOW Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Long COVID RECOVERY NOW Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Air Carrier Access Amendments Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Air Carrier Access Amendments Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Air Carrier Access Amendments Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
2023 Reauthorization of the Federal Aviation Administration, support passage S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Air Carrier Access Amendments Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.XX FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Telehealth Expansion Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Telehealth Expansion Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Pharmacy Benefit Manager Sunshine and Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Pharmacy Benefit Manager Sunshine and Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Pharmacy Benefit Manager Sunshine and Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
PASTEUR Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
PASTEUR Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Providers and Payers COMPETE Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Providers and Payers COMPETE Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Providers and Payers COMPETE Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
PATIENT Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
PATIENT Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
PATIENT Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Fiscal Responsibility Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
Fiscal Responsibility Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
Fiscal Responsibility Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
FAA Reauthorization Act of 2024
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.XX FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
FAA Reauthorization Act of 2024
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
FAA Reauthorization Act of 2024
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
CONNECT for Health Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
CONNECT for Health Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Preparedness and Response Reauthorization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Preparedness and Response Reauthorization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Preparedness and Response Reauthorization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Preparing for All Hazards and Pathogens Reauthorization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Preparing for All Hazards and Pathogens Reauthorization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Preparing for All Hazards and Pathogens Reauthorization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Transparency in Coverage Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Transparency in Coverage Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Transparency in Coverage Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Hidden Fee Disclosure Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Hidden Fee Disclosure Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Hidden Fee Disclosure Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Protecting Health Care for All Patients Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Protecting Health Care for All Patients Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Protecting Health Care for All Patients Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Protecting Health Care for All Patients Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community.
Telehealth Benefit Expansion for Workers Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Telehealth Benefit Expansion for Workers Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Telehealth Benefit Expansion for Workers Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
HELP Copays Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
HELP Copays Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
HELP Copays Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community.
HELP Copays Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Ensuring Timely Access to Generics Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Ensuring Timely Access to Generics Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Prescription Pricing for the People Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Prescription Pricing for the People Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Prescription Pricing for the People Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Prescription Pricing for the People Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Prescription Pricing for the People Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage
Prescription Pricing for the People Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Prescription Pricing for the People Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Pharmacy Benefit Manager Transparency Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Pharmacy Benefit Manager Transparency Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community.
Pharmacy Benefit Manager Transparency Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Pharmacy Benefit Manager Transparency Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Pharmacy Benefit Manager Reform Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Pharmacy Benefit Manager Reform Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Pharmacy Benefit Manager Reform Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Prevent Government Shutdowns Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Prevent Government Shutdowns Act of 2023
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
H.R.1 - One Big Beautiful Bill Act Continued to advocate on H.R.1 implementation. In July, the National MS Society commented on CMSs Medicaid Community Engagement Requirement centering around administrative barriers that could jeopardize health coverage for people living with MS and other chronic conditions, and urging CMS to maintain robust protections and exemptions to ensure uninterrupted access to care and treatment.
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 In July, the National MS Society submitted comments on the Office of Management and Budgets (OMB) proposed Regulation for Federal Financial Assistance, expressing concern over impacts the rule may have on grant review and federal research investments.
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2023 · fourth_quarter · Q4
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage (awaiting bill number) S.2254, Medicare PBM Accountability Act, support passage
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2023 · third_quarter · Q3
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage (awaiting bill number) S.2254, Medicare PBM Accountability Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2023 · second_quarter · Q2
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.XXX, Modernizing and Ensuring PBM Accountability Act, support passage S.2254, Medicare PBM Accountability Act, support passage
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.XX FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2023 · first_quarter · Q1
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs.
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community.
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage
2023 Reauthorization of the Federal Aviation Administration, support passage S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · third_quarter · 3A
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · fourth_quarter · 4A
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage H.R. 2954- Securing a Strong Retirement Act of 2021 (SECURE Act), support passage Enhancing American Retirement Now Act (bill number forthcoming, Senate Finance retirement package), support passage H.R. 5376- Inflation Reduction Act- support tax provisions and extensions included.
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · fourth_quarter · Q4
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · third_quarter · 3A
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 5376, Inflation Reduction Act (support passage, particularly drug pricing provisions)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · third_quarter · 3A
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage H.R. 2954- Securing a Strong Retirement Act of 2021 (SECURE Act), support passage Enhancing American Retirement Now Act (bill number forthcoming, Senate Finance retirement package), support passage H.R. 5376- Inflation Reduction Act- support tax provisions and extensions included.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · third_quarter · Q3
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage H.R. 2954- Securing a Strong Retirement Act of 2021 (SECURE Act), support passage Enhancing American Retirement Now Act (bill number forthcoming, Senate Finance retirement package), support passage H.R. 5376- Inflation Reduction Act- support tax provisions and extensions included.
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 5376, Inflation Reduction Act (support passage, particularly drug pricing provisions)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · second_quarter · Q2
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage H.R. 2954- Securing a Strong Retirement Act of 2021 (SECURE Act), support passage Enhancing American Retirement Now Act (bill number forthcoming, Senate Finance retirement package), support passage
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage H.R. 2455 - The Resetting the IMPACT Act (TRIA) of 2021." - support passage H.R. 1319- The American Rescue Plan Act of 2021, support passage H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · first_quarter · Q1
Prescription Drug User Fee Act- supporting goals of the Prescription Drug User Fee commitment letter between the Food and Drug Administration and industry partners and legislation to reauthorize the prescription drug user fee program at FDA and resulting initiative. Supporting funding increase for the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration in FY22 Appropriations bills and other research focus funding supplemental legislation. H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage Senator Kaine Accelerated Approval bill - support passage S. 3799 Prevent Pandemics Act - support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2021 · fourth_quarter · Q4
Prescription Drug User Fee Act- supporting goals of the Prescription Drug User Fee commitment letter between the Food and Drug Administration and industry partners and legislation to reauthorize the prescription drug user fee program at FDA and resulting initiative. Supporting funding increase for the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration in FY22 Appropriations bills and other research focus funding supplemental legislation. H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2021 · third_quarter · Q3
H.R. 1319 - American Rescue Plan Act of 2021 - support passage H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2021 · second_quarter · Q2
H.R. 1319 - American Rescue Plan Act of 2021 - support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2021 · first_quarter · Q1
H.R.1319- The American Rescue Plan Act of 2021 - support passage Supporting -$20 million for the MS Research Program in the final FY22 Defense Appropriations Act (no bill number yet)
Prescription Drug User Fee Act Cures 2.0 discussion draft Funding increase for the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration in final FY22 Appropriations bills
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2020 · fourth_quarter · Q4
H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage H.R. 7647, To provide for a COVID-19-related delay regarding annual limitation on cost-sharing for group health plans and individual and small group health insurance coverage, support passage H.R. 2293, the Protecting Access to Wheelchairs Act, support passage H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage S. 691 - Medicare Extra Rx Help Act- support passage S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage oMenendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption oMenendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D, support adoption S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage. S.4468, COVID-19 Treatment Coverage Act, support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2020 · third_quarter · Q3
H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage H.R. 7647 H.R. 2293, the Protecting Access to Wheelchairs Act, support passage H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage S. 691 - Medicare Extra Rx Help Act- support passage S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage oMenendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption oMenendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D, support adoption S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage. S.4468, COVID-19 Treatment Coverage Act, support passage
H.R. 7608, H.R. 7616 - Labor, Health and Human Services, Education, Defense, Military Construction and Veterans Affairs, and Food and Drug Administration Appropriations Acts for fiscal year 2021 Defense Appropriations Act, 2021, support $20 million for the MSRP. Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2021: $471 million for the Agency for Healthcare Research and Quality (AHRQ) $8.45 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $10 million for the Lifespan Respite Care Program; Robust funding for Medicare and Medicaid and protection of Medicaids current financing structure At least $44.7 billion for the National Institute of Health (NIH), including funds provided to the agency through the 21st Century Cures Act (P.L. 114-255) for targeted initiative; $150 million for the Patient Centered Outcomes Research Institute (PCORI); and $13.5 billion for the Social Security Administration to include report language that directs a review of funding for all of the VA Centers of Excellence and enact a strategy that ensures these important programs are funded in a consistent and transparent manner and that the funding meets the scope and scale of their missions. $3.6 billion for the Food and Drug Administration Supporting same funding levels in Senate for these programs. H.R. 6202 Families First Coronavirus Response Act - supplemental appropriations and health provisions related to the COVID-19 pandemic, support passage S.3548 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)- supplemental appropriations and health/economic stimulus relating to the COVID-19 pandemic, support passage.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2020 · second_quarter · Q2
N/A
N/A
N/A
- H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -H.R. 19 - Lower Costs, More Cures Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage - H.R. 6417, Protecting Cures Act of 2020, support passage - H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption S, 1801, Low Cost Generics Act of 2019, support passage S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage. - H.R. 1425 Patient Protection and Affordable Care Enhancement Act, support - H.R. 6514, Worker Health Coverage Protection Act, Support - H.R. 3832, S. 1257, Legacy IRA Act, Support - H.R. 6408 - Save the Organizations that Serve America Act - S.3544/H.R.6305 - Coronavirus Relief for Seniors and People with Disabilities Act of 2020, support -RESTART Act (S. 3814), Oppose - Paycheck Protection Program Flexibility Act of 2020(S. 3833/H.R. 7010/H.R.6886) Support -Help Charities Protect Communities Act (Rep. Beatty), bill number to be determined. Support - S.Amdt. 1566 to the CARES Act,Charitable Giving Amendment.Increases the $300 limit on the charitable giving deduction to one-third of the standard deduction ($4,000 for an individual filer/$8,000 for married joint filers) for the remainder of 2020. Support.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2020 · first_quarter · Q1
N/A
N/A
N/A
- H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -H.R. 19 - Lower Costs, More Cures Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage - H.R. 6417, Protecting Cures Act of 2020, support passage - H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption S, 1801, Low Cost Generics Act of 2019, support passage S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2019 · fourth_quarter · 4A
N/A
N/A
N/A
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption -S, 1801, Low Cost Generics Act of 2019, support passage -S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2019 · fourth_quarter · Q4
H.R. 2740- Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 oIncluded department of Defense Appropriations Act, 2019, support $16 million for the MSRP. Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $41.6 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $10 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. H.R. 3055- Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 oSupporting $3.3 billion for the Food and Drug Administration. Supporting same funding levels in Senate for these programs.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2019 · third_quarter · Q3
N/A
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation Technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2019 · second_quarter · Q2
N/A
N/A
N/A
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation Technology Act, support passage. -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2019 · first_quarter · Q1
N/A
- Department of Defense Appropriations Act, 2019, support $16 million for the MSRP. - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $41.6 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $20 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support $3.3 billion for the Food and Drug Administration.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2018 · fourth_quarter · 4A
-H.R. 5004/S. 1318, Air Carrier Access Amendments Act, support passage. -Reauthorization of the Federal Aviation Administration, support provisions to improve air travel for passengers with disabilities.
S.2987/ H.R. 5515, National Defense Authorization Act for FY19, support funding and scope of Congressionally Directed Medical Research Programs within the Department of Defense.
Bipartisan Health Care Stabilization Act, support bipartisan efforts led by Senators Alexander and Murray to stabilize and improve the individual health insurance market while protecting people with chronic conditions. -H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage. - H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. -H.R. 2077, Restoring Patients Voice Act, support passage. -S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, support passage. -H.R. 4841/S. 2908, Standardizing Electronic Prior Authorization for Safe Prescribing Act, support passage. - H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories. -H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2018 · fourth_quarter · Q4
S.2987/ H.R. 5515, National Defense Authorization Act for FY19, support funding and scope of Congressionally Directed Medical Research Programs within the Department of Defense.
Bipartisan Health Care Stabilization Act, support bipartisan efforts led by Senators Alexander and Murray to stabilize and improve the individual health insurance market while protecting people with chronic conditions. -H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage. - H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. -H.R. 2077, Restoring Patients Voice Act, support passage. -S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, support passage. -H.R. 4841/S. 2908, Standardizing Electronic Prior Authorization for Safe Prescribing Act, support passage. - H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories. -H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2018 · third_quarter · Q3
- Department of Defense Appropriations Act, 2019, support $12 million for the MSRP. - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $39.3 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $5 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support $3.32 billion for the Food and Drug Administration.
-Bipartisan Health Care Stabilization Act, support bipartisan efforts led by Senators Alexander and Murray to stabilize and improve the individual health insurance market while protecting people with chronic conditions. -H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage. - H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. -H.R. 2077, Restoring Patients Voice Act, support passage. -S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, support passage. -H.R. 4841/S. 2908, Standardizing Electronic Prior Authorization for Safe Prescribing Act, support passage. - H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories. -H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2018 · second_quarter · Q2
S.2987/ H.R. 5515, National Defense Authorization Act for FY19, support funding and scope of Congressionally Directed Medical Research Programs within the Department of Defense.
-Bipartisan Health Care Stabilization Act, support bipartisan efforts led by Senators Alexander and Murray to stabilize and improve the individual health insurance market while protecting people with chronic conditions. -H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage. - H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. -H.R. 2077, Restoring Patients Voice Act, support passage. -S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, support passage. -H.R. 4841/S. 2908, Standardizing Electronic Prior Authorization for Safe Prescribing Act, support passage. - H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories. -H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2018 · first_quarter · Q1
-Bipartisan Health Care Stabilization Act, support bipartisan efforts led by Senators Alexander and Murray to stabilize and improve the individual health insurance market while protecting people with chronic conditions. -H.R. 807/S.253, Medicare Access to Rehabilitation Services Act, support passage. -H.R. 1892, Bipartisan Budget Act of 2018, support repeal of the Medicare therapy cap. -S. 1028/H.R. 3759, RAISE Family Caregivers Act, support passage. -H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage. - H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. -H.R. 2077, Restoring Patients Voice Act, support passage. -S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, support passage. - H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories. -H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2017 · fourth_quarter · Q4
-H.R. 2810/S.1519, National Defense Authorization Act (NDAA) of 2018, protect Congressionally Directed Medical Research Programs.
-Bipartisan Health Care Stabilization Act of 2017, support bipartisan efforts led by Senators Alexander and Murray to stabilize and improve the individual health insurance market while protecting people with chronic conditions. -H.R. 1, Tax Cuts and Jobs Act, oppose repeal of the individual mandate, preserve medical expense deduction, preserve the Disabled Tax Credit, protect entitlement programs, protect charitable giving by including a universal charitable giving deduction and protect tuition assistance and student loans. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories. -H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -H.R. 807/S.253, Medicare Access to Rehabilitation Services Act, support passage. -H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage. - H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2123/S. 925 Veterans E-Health and Telemedicine Support Act of 2017 -H.R. 2556/S. 1016 Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017 -S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 -S. 1028/H.R. 3759, RAISE Family Caregivers Act, support passage. -HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act -(H.R. 3931 / S. 1950), Excellence in Mental Health and Addiction Treatment Expansion Act, support passage.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2017 · third_quarter · 3A
-H.R. 1628, oppose the American Health Care Act and Better Care Reconciliation Act. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486, support passage to protect access to complex rehabilitative technology accessories. -H.R. 807/S.253 , Medicare Access to Rehabilitation Services Act, support passage. -H.R. 2556/S. 1016 Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017, support passage. -S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, support passage.
-H.R. 1628, oppose the American Health Care Act, Better Care Reconciliation Act and Obamacare Repeal Reconciliation Act. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories. -H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -H.R. 807/S.253 , Medicare Access to Rehabilitation Services Act, support passage. -H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage. -H.R. 2430/ S. 934, FDA Reauthorization Act of 2017, support passage. - H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2123/S. 925 Veterans E-Health and Telemedicine Support Act of 2017, support passage. -H.R. 2556/S. 1016 Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017, support passage. -S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, support passage. -S. 1028/H.R. 3759, RAISE Family Caregivers Act, support passage. -HR 2575, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2017 · third_quarter · Q3
H.R. 2810/S.15190-National Defense Authorization Act (NDAA) of 2018, oppose amendment that threatens MS Research Program through the Congressionally Directed Medical Research Program.
- Department of Defense Appropriations Act, 2018, support $10 million for the Multiple Sclerosis Congressionally Directed Medical Research Program (CDMRP). - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2018, support a $2 billion increase above FY 2017 levels for the NIH; Support $5million for the Centers for Disease Control and Prevention to implement the National Neurological Conditions Surveillance System; $150 million for the Patient Centered Outcomes Research Institute (PCORI); $5 million for the Lifespan Respite Care Program; an increase over our recommended FY17 funding level of $13.067 billion for the SSAs administrative budget; and $364 million for the Agency for Healthcare Research and Quality (AHRQ). - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2018, support $2.8 billion for the FDA; the $500 million provided for targeted programs at the FDA by the 21st Century Cures Act; and an additional $1.35 billion in medical product user fees.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2017 · second_quarter · Q2
None this quarter.
-- Department of Defense Appropriations Act, 2017, support $6 million for the Multiple Sclerosis Congressionally Directed Medical Research Program (CDMRP). - Department of Defense Appropriations Act, 2018, support $10 million for the Multiple Sclerosis Congressionally Directed Medical Research Program (CDMRP). - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2017, support at least $34.5 billion for the National Institutes of Health (NIH), $4 million for the Lifespan Respite Care Program and $13 billion for the Social Security Administrations (SSA) administrative budget. - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2018, support a $2 billion increase above FY 2017 levels for the NIH; $150 million for the Patient Centered Outcomes Research Institute (PCORI); $5 million for the Lifespan Respite Care Program; an increase over our recommended FY17 funding level of $13.067 billion for the SSAs administrative budget; and $364 million for the Agency for Healthcare Research and Quality (AHRQ). - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2017, support robust funding for the Food and Drug Administration (FDA). - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2018, support $2.8 billion for the FDA; the $500 million provided for targeted programs at the FDA by the 21st Century Cures Act; and an additional $1.35 billion in medical product user fees.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2017 · first_quarter · Q1
None this quarter.
-H.R. 1628, oppose the American Health Care Act. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486, support passage to protect access to complex rehabilitative technology accessories. -Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program.
- Department of Defense Appropriations Act, 2017, support $6 million for the Multiple Sclerosis Congressionally Directed Medical Research Program (CDMRP). - Department of Defense Appropriations Act, 2018, support $10 million for the Multiple Sclerosis Congressionally Directed Medical Research Program (CDMRP). - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2017, support at least $34.5 billion for the National Institutes of Health (NIH), $4 million for the Lifespan Respite Care Program and $13 billion for the Social Security Administrations (SSA) administrative budget. - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2018, support a $2 billion increase above FY 2017 levels for the NIH; $150 million for the Patient Centered Outcomes Research Institute (PCORI); $5 million for the Lifespan Respite Care Program; an increase over our recommended FY17 funding level of $13.067 billion for the SSAs administrative budget; and $364 million for the Agency for Healthcare Research and Quality (AHRQ). - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2017, support robust funding for the Food and Drug Administration (FDA). - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2018, support $2.8 billion for the FDA; the $500 million provided for targeted programs at the FDA by the 21st Century Cures Act; and an additional $1.35 billion in medical product user fees.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2016 · fourth_quarter · Q4
-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 34, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 4762/S. 2689, REGROW Act, express concerns about patient safety and oppose inclusion of current version of bill in the Senate Innovations package. - H.R. 34, 21st Century Cures Act, oppose language that would weaken FDA safety/efficacy standards and support language that maintain FDA safety/efficacy standards and providing a clear pathway to market for cellular products.
- Department of Defense Appropriations Act, 2017, support $6 million for the Multiple Sclerosis Congressionally Directed Medical Research Program (CDMRP). - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2017, support at least $34.5 billion for the National Institutes of Health, $5 million for the Lifespan Respite Care Program and $13 billion for the Social Security Administrations administrative budget. - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2017, support robust funding for the Food and Drug Administration. -H.R. 2028, Further Continuing and Security Assistance Appropriations Act, 2017, support passage to continue funding government-run programs and services for people with MS.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2016 · third_quarter · Q3
-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 1516/S. 1013, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 3229/S. 2196, support passage to protect access to complex rehabilitative technology accessories. -H.R. 3913, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program.
- Department of Defense Appropriations Act, 2017, support $6 million for the Multiple Sclerosis Congressionally Directed Medical Research Program (CDMRP). - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2017, support at least $34.5 billion for the National Institutes of Health, $5 million for the Lifespan Respite Care Program and $13 billion for the Social Security Administrations administrative budget. - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2017, support robust funding for the Food and Drug Administration.
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage H.R. 2954- Securing a Strong Retirement Act of 2021 (SECURE Act), support passage Enhancing American Retirement Now Act (bill number forthcoming, Senate Finance retirement package), support passage H.R. 5376- Inflation Reduction Act- support tax provisions and extensions included.
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 5376, Inflation Reduction Act (support passage, particularly drug pricing provisions)
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
H.R. 2617, Consolidated Appropriations Act FY 2023 Omnibus Package-support final passage. FY2023 LHHS Appropriations Act: At least $49 billion for the NIHs base and any funding for the new ARPA-H, or for other targeted programs, including pandemic protection. A least $5 million for the CFC National Neurological Conditions Surveillance System. FY2023 House/Senate Military Construction, VA, and Related Agencies: Support double funding for the VA MS Centers of Excellence ($5 million) and the following report language: The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments in the multiple sclerosis and Parkinsons dases centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. FY2023 Defense Appropriations Act - support $22 million for MS Research Program: Support $22 million for the MS Research Program
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage H.R. 2954- Securing a Strong Retirement Act of 2021 (SECURE Act), support passage Enhancing American Retirement Now Act (bill number forthcoming, Senate Finance retirement package), support passage H.R. 5376- Inflation Reduction Act- support tax provisions and extensions included.
H.R. 2617, Consolidated Appropriations Act FY 2023 Omnibus Package-support final passage. FY2023 LHHS Appropriations Act: At least $49 billion for the NIHs base and any funding for the new ARPA-H, or for other targeted programs, including pandemic protection. A least $5 million for the CFC National Neurological Conditions Surveillance System. FY2023 House/Senate Military Construction, VA, and Related Agencies: Support double funding for the VA MS Centers of Excellence ($5 million) and the following report language: The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments in the multiple sclerosis and Parkinsons dases centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. FY2023 Defense Appropriations Act - support $22 million for MS Research Program: Support $22 million for the MS Research Program
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage H.R. 2954- Securing a Strong Retirement Act of 2021 (SECURE Act), support passage Enhancing American Retirement Now Act (bill number forthcoming, Senate Finance retirement package), support passage H.R. 5376- Inflation Reduction Act- support tax provisions and extensions included.
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 5376, Inflation Reduction Act (support passage, particularly drug pricing provisions)
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
H.R. 1319 - American Rescue Plan Act - support passage COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684
H.R. 1319 - American Rescue Plan Act of 2021 - support passage H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress
H.R.1319- The American Rescue Plan Act of 2021 - support passage FY 22 House/Senate Defense Appropriations Act -Supporting -$20 million for the MS Research Program FY 22 House/Senate Labor, Health and Human Services and Education Act-$500 million for the Agency for Healthcare Research and Quality (AHRQ),$10 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $14.2 million for the Lifespan Respite Care Program; Robust support for Medicare and Medicaid and protection of Medicaids current financing structure; and at least $46.1 billion for the National Institute of Health (NIH), full funding for the Patient Centered Outcomes Research Institute (PCORI); and at least $13.5 billion for the Social Security Administrations administrative budget. FY 22 House/Senate - Military Construction, Veterans Affairs, and Related Agencies Appropriations bill - sustainable, predictable funding for the VA Multiple Sclerosis Centers of Excellence. Additionally, we urge this Committee to include report language that expresses its support for all the Neurology Centers of Excellence in the FY22 appropriations report language. Our suggested language is below: Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Department is directed to significantly increase its investment to maintain and expand existing centers of excellence within the VA dedicated to these conditions to enhance their value in coordinating innovative clinical care, education, and research efforts. No later than 120 days after enactment of this Act the Committee directs the Secretary to submit a report to the Committees providing details on opportunities to enhance care for veterans with neurologic conditions, including potential collaboration between the neurology centers of excellence. H. Res. 101/S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, support passage FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage H.R. 2954- Securing a Strong Retirement Act of 2021 (SECURE Act), support passage
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage H.R. 2455 - The Resetting the IMPACT Act (TRIA) of 2021." - support passage H.R. 1319- The American Rescue Plan Act of 2021, support passage H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
H.R.1319- The American Rescue Plan Act of 2021 - support passage FY 22 House/Senate Defense Appropriations Act -Supporting -$20 million for the MS Research Program FY 22 House/Senate Labor, Health and Human Services and Education Act-$500 million for the Agency for Healthcare Research and Quality (AHRQ),$10 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $14.2 million for the Lifespan Respite Care Program; Robust support for Medicare and Medicaid and protection of Medicaids current financing structure; and at least $46.1 billion for the National Institute of Health (NIH), full funding for the Patient Centered Outcomes Research Institute (PCORI); and at least $13.5 billion for the Social Security Administrations administrative budget. FY 22 House/Senate - Military Construction, Veterans Affairs, and Related Agencies Appropriations bill - sustainable, predictable funding for the VA Multiple Sclerosis Centers of Excellence. Additionally, we urge this Committee to include report language that expresses its support for all the Neurology Centers of Excellence in the FY22 appropriations report language. Our suggested language is below: Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Department is directed to significantly increase its investment to maintain and expand existing centers of excellence within the VA dedicated to these conditions to enhance their value in coordinating innovative clinical care, education, and research efforts. No later than 120 days after enactment of this Act the Committee directs the Secretary to submit a report to the Committees providing details on opportunities to enhance care for veterans with neurologic conditions, including potential collaboration between the neurology centers of excellence. H. Res. 101/S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, support passage FY2023 Defense Appropriations Act- support $22 million for the MS Research Program" FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System
H.R. 1319 - American Rescue Plan Act - support passage COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 1319 - American Rescue Plan Act of 2021 - support passage H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage H.R. 2455 - The Resetting the IMPACT Act (TRIA) of 2021." - support passage H.R. 1319- The American Rescue Plan Act of 2021, support passage H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act
H.R. 1319 - American Rescue Plan Act of 2021 - support passage H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage
H.R.1319- The American Rescue Plan Act of 2021 - support passage FY 22 House/Senate Defense Appropriations Act -Supporting -$20 million for the MS Research Program FY 22 House/Senate Labor, Health and Human Services and Education Act-$500 million for the Agency for Healthcare Research and Quality (AHRQ),$10 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $14.2 million for the Lifespan Respite Care Program; Robust support for Medicare and Medicaid and protection of Medicaids current financing structure; and at least $46.1 billion for the National Institute of Health (NIH), full funding for the Patient Centered Outcomes Research Institute (PCORI); and at least $13.5 billion for the Social Security Administrations administrative budget. FY 22 House/Senate - Military Construction, Veterans Affairs, and Related Agencies Appropriations bill - sustainable, predictable funding for the VA Multiple Sclerosis Centers of Excellence. Additionally, we urge this Committee to include report language that expresses its support for all the Neurology Centers of Excellence in the FY22 appropriations report language. Our suggested language is below: Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Department is directed to significantly increase its investment to maintain and expand existing centers of excellence within the VA dedicated to these conditions to enhance their value in coordinating innovative clinical care, education, and research efforts. No later than 120 days after enactment of this Act the Committee directs the Secretary to submit a report to the Committees providing details on opportunities to enhance care for veterans with neurologic conditions, including potential collaboration between the neurology centers of excellence. H. Res. 101/S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, support passage
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage
H.R. 1319 - American Rescue Plan Act - support passage COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage H.R. 2455 - The Resetting the IMPACT Act (TRIA) of 2021." - support passage H.R. 1319- The American Rescue Plan Act of 2021, support passage H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage
H.R. 1319 - American Rescue Plan Act - support passage COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R.1319- The American Rescue Plan Act of 2021 - support passage FY 22 House/Senate Defense Appropriations Act -Supporting -$20 million for the MS Research Program FY 22 House/Senate Labor, Health and Human Services and Education Act-$500 million for the Agency for Healthcare Research and Quality (AHRQ),$10 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $14.2 million for the Lifespan Respite Care Program; Robust support for Medicare and Medicaid and protection of Medicaids current financing structure; and at least $46.1 billion for the National Institute of Health (NIH), full funding for the Patient Centered Outcomes Research Institute (PCORI); and at least $13.5 billion for the Social Security Administrations administrative budget. FY 22 House/Senate - Military Construction, Veterans Affairs, and Related Agencies Appropriations bill - sustainable, predictable funding for the VA Multiple Sclerosis Centers of Excellence. Additionally, we urge this Committee to include report language that expresses its support for all the Neurology Centers of Excellence in the FY22 appropriations report language. Our suggested language is below: Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Department is directed to significantly increase its investment to maintain and expand existing centers of excellence within the VA dedicated to these conditions to enhance their value in coordinating innovative clinical care, education, and research efforts. No later than 120 days after enactment of this Act the Committee directs the Secretary to submit a report to the Committees providing details on opportunities to enhance care for veterans with neurologic conditions, including potential collaboration between the neurology centers of excellence. H. Res. 101/S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, support passage
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684
Supporting Paid Family and Medical Leave policies and provisions within the Budget reconciliation and infrastructure packages
Prescription Drug User Fee Act- supporting goals of the Prescription Drug User Fee commitment letter between the Food and Drug Administration and industry partners and legislation to reauthorize the prescription drug user fee program at FDA and resulting initiative. Cures 2.0 discussion draft- supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal. Supporting funding increase for the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration in FY22 Appropriations bills and other research focus funding supplemental legislation. H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Prescription Drug User Fee Act- supporting goals of the Prescription Drug User Fee commitment letter between the Food and Drug Administration and industry partners and legislation to reauthorize the prescription drug user fee program at FDA and resulting initiative. Cures 2.0 discussion draft- supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal. Supporting funding increase for the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration in FY22 Appropriations bills and other research focus funding supplemental legislation.
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage
H.R. 1319 - American Rescue Plan Act - support passage COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R.1319- The American Rescue Plan Act of 2021 - support passage FY 22 House/Senate Defense Appropriations Act -Supporting -$20 million for the MS Research Program FY 22 House/Senate Labor, Health and Human Services and Education Act-$500 million for the Agency for Healthcare Research and Quality (AHRQ),$10 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $14.2 million for the Lifespan Respite Care Program; Robust support for Medicare and Medicaid and protection of Medicaids current financing structure; and at least $46.1 billion for the National Institute of Health (NIH), full funding for the Patient Centered Outcomes Research Institute (PCORI); and at least $13.5 billion for the Social Security Administrations administrative budget. FY 22 House/Senate - Military Construction, Veterans Affairs, and Related Agencies Appropriations bill - sustainable, predictable funding for the VA Multiple Sclerosis Centers of Excellence. Additionally, we urge this Committee to include report language that expresses its support for all the Neurology Centers of Excellence in the FY22 appropriations report language. Our suggested language is below: Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Department is directed to significantly increase its investment to maintain and expand existing centers of excellence within the VA dedicated to these conditions to enhance their value in coordinating innovative clinical care, education, and research efforts. No later than 120 days after enactment of this Act the Committee directs the Secretary to submit a report to the Committees providing details on opportunities to enhance care for veterans with neurologic conditions, including potential collaboration between the neurology centers of excellence.
Supporting Administration infrastructure package initial discussions including the American Jobs Act.
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
H.R. 1319 - American Rescue Plan Act - COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans.
H.R. 1319 - American Rescue Plan Act of 2021 - support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
H.R. 985, Fair Access for Safe and Timely Generics Act of 2019 (FAST Generics Act), support passage. H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage H.R. 2781 - Empower for Health Act of 2019, support passage H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage H.R. 3630 - No Surprises Act, support passage H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. H.R 3 - Lower Drug Costs Now Act of 2019, support passage H.R. 19 - Lower Costs, More Cures Act of 2019, support passage H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage H.R. 6417, Protecting Cures Act of 2020, support passage H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage S. 1935, Family Coverage Act, support passage. S.1556, No Junk Plans Act, support passage. S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage S. 659, Biologic Patent Transparency Act, support passage S.1895 - Lower Health Care Costs Act, support passage S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage S. 1801, Low Cost Generics Act of 2019, support passage H.R. 1425 Patient Protection and Affordable Care Enhancement Act, support H.R. 6514, Worker Health Coverage Protection Act, Support H.R. 3832, S. 1257, Legacy IRA Act, Support H.R. 6408 - Save the Organizations that Serve America Act S.3544/H.R.6305 - Coronavirus Relief for Seniors and People with Disabilities Act of 2020, support S. 3815, RESTART Act, Oppose S. 3833/H.R. 7010/H.R.6886, Paycheck Protection Program Flexibility Act of 2020, Support S. 4032/H.R. 7324, Universal Giving Pandemic Response Act. Support passage H.R. 6892-Help Charities Protect Communities Act, Support - S.Amdt. 1566 to the CARES Act, Charitable Giving oAmendment Increases the $300 limit on the charitable giving deduction to one-third of the standard deduction ($4,000 for an individual filer/$8,000 for married joint filers) for the remainder of 2020. Support. H.R. 7663-Protecting Access to Post-COVID-19 Telehealth Act, support passage H.R. 6644/S. 3741 - Health Care At Home Act, support passage H.R. 7391- the Protect Telehealth Access Act, support passage S. 3998- the Enhancing Preparedness Through Telehealth Act, support passage
Signed on to letter dated 4.16.20 to HHS Secretary Azar and Office of Civil Rights (OCR) Director Severino urging further executive action and additional guidance to assure any care rationing plans fully comply with federal anti-discrimination laws.
H.R. 7308/S.4286 Research Investment to Spark the Economy Act (RISE) Act, support passage oSupport Markey Amendment in the Nature of a Substitute to add provisions allowing for $2 billion in funding for non-profit research stalled by the COVID-19 pandemic and $1 billion in funding to aid in clinical trial sites. S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization.
H.R. 7608, H.R. 7616 - Labor, Health and Human Services, Education, Defense, Military Construction and Veterans Affairs, and Food and Drug Administration Appropriations Acts for fiscal year 2021 Defense Appropriations Act, 2021, support $20 million for the MSRP. Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2021: $471 million for the Agency for Healthcare Research and Quality (AHRQ) $8.45 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $10 million for the Lifespan Respite Care Program; Robust funding for Medicare and Medicaid and protection of Medicaids current financing structure At least $44.7 billion for the National Institute of Health (NIH), including funds provided to the agency through the 21st Century Cures Act (P.L. 114-255) for targeted initiative; $150 million for the Patient Centered Outcomes Research Institute (PCORI); and $13.5 billion for the Social Security Administration to include report language that directs a review of funding for all of the VA Centers of Excellence and enact a strategy that ensures these important programs are funded in a consistent and transparent manner and that the funding meets the scope and scale of their missions. $3.6 billion for the Food and Drug Administration Supporting same funding levels in Senate for these programs. H.R. 6202 Families First Coronavirus Response Act - supplemental appropriations and health provisions related to the COVID-19 pandemic, support passage S.3548 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)- supplemental appropriations and health/economic stimulus relating to the COVID-19 pandemic, support passage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
H.R. 7308/S.4286 Research Investment to Spark the Economy Act (RISE) Act, support passage oSupport Markey Amendment in the Nature of a Substitute to add provisions allowing for $2 billion in funding for non-profit research stalled by the COVID-19 pandemic and $1 billion in funding to aid in clinical trial sites. S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization.
H.R. 985, Fair Access for Safe and Timely Generics Act of 2019 (FAST Generics Act), support passage. H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage H.R. 2781 - Empower for Health Act of 2019, support passage H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage H.R. 3630 - No Surprises Act, support passage H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. H.R 3 - Lower Drug Costs Now Act of 2019, support passage H.R. 19 - Lower Costs, More Cures Act of 2019, support passage H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage H.R. 6417, Protecting Cures Act of 2020, support passage H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage S. 1935, Family Coverage Act, support passage. S.1556, No Junk Plans Act, support passage. S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage S. 659, Biologic Patent Transparency Act, support passage S.1895 - Lower Health Care Costs Act, support passage S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage S. 1801, Low Cost Generics Act of 2019, support passage H.R. 1425 Patient Protection and Affordable Care Enhancement Act, support H.R. 6514, Worker Health Coverage Protection Act, Support H.R. 3832, S. 1257, Legacy IRA Act, Support H.R. 6408 - Save the Organizations that Serve America Act S.3544/H.R.6305 - Coronavirus Relief for Seniors and People with Disabilities Act of 2020, support S. 3815, RESTART Act, Oppose S. 3833/H.R. 7010/H.R.6886, Paycheck Protection Program Flexibility Act of 2020, Support S. 4032/H.R. 7324, Universal Giving Pandemic Response Act. Support passage H.R. 6892-Help Charities Protect Communities Act, Support - S.Amdt. 1566 to the CARES Act, Charitable Giving oAmendment Increases the $300 limit on the charitable giving deduction to one-third of the standard deduction ($4,000 for an individual filer/$8,000 for married joint filers) for the remainder of 2020. Support. H.R. 7663-Protecting Access to Post-COVID-19 Telehealth Act, support passage H.R. 6644/S. 3741 - Health Care At Home Act, support passage H.R. 7391- the Protect Telehealth Access Act, support passage S. 3998- the Enhancing Preparedness Through Telehealth Act, support passage
Signed on to letter dated 4.16.20 to HHS Secretary Azar and Office of Civil Rights (OCR) Director Severino urging further executive action and additional guidance to assure any care rationing plans fully comply with federal anti-discrimination laws.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
H.R. 7608, H.R. 7616 - Labor, Health and Human Services, Education, Defense, Military Construction and Veterans Affairs, and Food and Drug Administration Appropriations Acts for fiscal year 2021 oDefense Appropriations Act, 2021, support $20 million for the MSRP. oDepartment of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2021: $471 million for the Agency for Healthcare Research and Quality (AHRQ) $8.45 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $10 million for the Lifespan Respite Care Program; Robust funding for Medicare and Medicaid and protection of Medicaids current financing structure; and At least $44.7 billion for the National Institute of Health (NIH), including funds provided to the agency through the 21st Century Cures Act (P.L. 114-255) for targeted initiative; $150 million for the Patient Centered Outcomes Research Institute (PCORI); and At least $13.5 billion for the Social Security Administration oto include report language that directs a review of funding for all of the VA Centers of Excellence and enact a strategy that ensures these important programs are funded in a consistent and transparent manner and that the funding meets the scope and scale of their missions. oSupporting $3.6 billion for the Food and Drug Administration Supporting same funding levels in Senate for these programs. H.R. 6202 Families First Coronavirus Response Act - supplemental appropriations and health provisions related to the COVID-19 pandemic, support passage S.3548 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)- supplemental appropriations and health/economic stimulus relating to the COVID-19 pandemic, support passage.
N/A
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
N/A
Bill Numbers TBD - Labor, Health and Human Services, Education, Defense, Military Construction and Veterans Affairs, and Food and Drug Administration Appropriations Acts for fiscal year 2021 oDefense Appropriations Act, 2021, support $20 million for the MSRP. oDepartment of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2021: $471 million for the Agency for Healthcare Research and Quality (AHRQ) $8.45 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $10 million for the Lifespan Respite Care Program; Robust funding for Medicare and Medicaid and protection of Medicaids current financing structure; and At least $44.7 billion for the National Institute of Health (NIH), including funds provided to the agency through the 21st Century Cures Act (P.L. 114-255) for targeted initiative; $150 million for the Patient Centered Outcomes Research Institute (PCORI); and At least $13.5 billion for the Social Security Administration oto include report language that directs a review of funding for all of the VA Centers of Excellence and enact a strategy that ensures these important programs are funded in a consistent and transparent manner and that the funding meets the scope and scale of their missions. oSupporting $3.6 billion for the Food and Drug Administration Supporting same funding levels in Senate for these programs. H.R. 6202 Families First Coronavirus Response Act - supplemental appropriations and health provisions related to the COVID-19 pandemic, support passage S.3548 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)- supplemental appropriations and health/economic stimulus relating to the COVID-19 pandemic, support passage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2740- Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 oIncluded department of Defense Appropriations Act, 2019, support $16 million for the MSRP. Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $41.6 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $10 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. H.R. 3055- Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 oSupporting $3.3 billion for the Food and Drug Administration. Supporting same funding levels in Senate for these programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
N/A
N/A
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2035, Lifespan Respite Care Reauthorization Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption -Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption -S, 1801, Low Cost Generics Act of 2019, support passage -S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.
N/A
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
N/A
N/A
H.R. 2740- Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 oIncluded department of Defense Appropriations Act, 2019, support $16 million for the MSRP. Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $41.6 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $10 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. H.R. 3055- Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 oSupporting $3.3 billion for the Food and Drug Administration. Supporting same funding levels in Senate for these programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2740- Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 oIncluded department of Defense Appropriations Act, 2019, support $16 million for the MSRP. Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $41.6 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $10 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. H.R. 3055- Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 oSupporting $3.3 billion for the Food and Drug Administration. Supporting same funding levels in Senate for these programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
N/A
- H.R. 965/ S. 340, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage - No bill number yet - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization.
N/A
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
- Department of Defense Appropriations Act, 2019, support $12 million for the MSRP. - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $39.3 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $5 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support $3.32 billion for the Food and Drug Administration.
H.R. 620, ADA Education and Reform Act, oppose passage.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
H.R. 620, ADA Education and Reform Act, oppose passage.
-H.R. 5004/S. 1318, Air Carrier Access Amendments Act, support passage. -Reauthorization of the Federal Aviation Administration, support provisions to improve air travel for passengers with disabilities.
- Department of Defense Appropriations Act, 2019, support $12 million for the MSRP. - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $39.3 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $5 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support $3.32 billion for the Food and Drug Administration.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
S.2987/ H.R. 5515, National Defense Authorization Act for FY19, support funding and scope of Congressionally Directed Medical Research Programs within the Department of Defense.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
- Department of Defense Appropriations Act, 2019, support $12 million for the MSRP. - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $39.3 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $5 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget. -Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support $3.32 billion for the Food and Drug Administration.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
- Department of Defense Appropriations Act, 2018, support $6 million for the Multiple Sclerosis Research Program (MSRP). - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2018, support $36.2 billion for the National Institutes of Health (NIH); $5 million for the Centers for Disease Control to establish the National Neurological Conditions Surveillance System; $150 million for the Patient Centered Outcomes Research Institute (PCORI); $3.36 million for the Lifespan Respite Care Program; an increase over our recommended FY17 funding level of $13.067 billion for the SSAs administrative budget; and $364 million for the Agency for Healthcare Research and Quality (AHRQ). - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2018, support $2.8 billion for the FDA; the $500 million provided for targeted programs at the FDA by the 21st Century Cures Act; and an additional $1.35 billion in medical product user fees. -H.R. 195, Continuing Resolution 2018, support continued funding for government agencies and programs important to people with MS through February 8, 2018. -H.R. 1892, Bipartisan Budget Act of 2018, support continued funding for government agencies and programs important to people with MS through March 23, 2018 and raising spending caps. -H.R. 1625, Consolidated Appropriations Act, 2018, support funding priorities for people with MS including $6 million for the MSRP, $36.2 billion for the NIH, $5 million for the National Neurological Conditions Surveillance System and $3.36 million for the Lifespan Respite Care Program. - Department of Defense Appropriations Act, 2019, support $12 million for the MSRP. - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support robust funding for the National Institutes of Health (NIH); $5 million for the Centers for Disease Control to establish the National Neurological Conditions Surveillance System; $5 million for the Lifespan Respite Care Program; robust funding for the SSAs administrative budget. - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support robust funding for the Food and Drug Administration.
None this quarter.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
- Department of Defense Appropriations Act, 2018, support $6 million for the Multiple Sclerosis Research Program (MSRP). - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2018, support $36.2 billion for the National Institutes of Health (NIH); $5 million for the Centers for Disease Control to establish the National Neurological Conditions Surveillance System; $150 million for the Patient Centered Outcomes Research Institute (PCORI); $3.36 million for the Lifespan Respite Care Program; an increase over our recommended FY17 funding level of $13.067 billion for the SSAs administrative budget; and $364 million for the Agency for Healthcare Research and Quality (AHRQ). - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2018, support $2.8 billion for the FDA; the $500 million provided for targeted programs at the FDA by the 21st Century Cures Act; and an additional $1.35 billion in medical product user fees. -H.R. 601, Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017, support continued funding for government agencies and programs important to people with MS through December 8, 2017. -H.J.Res. 123, support continued funding for government agencies and programs important to people with MS through December 22, 2017. -H.R. 1370, support continued funding for government agencies and programs important to people with MS through January 19, 2018.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
- Department of Defense Appropriations Act, 2018, support $10 million for the Multiple Sclerosis Congressionally Directed Medical Research Program (CDMRP). - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2018, support a $2 billion increase above FY 2017 levels for the NIH; Support $5million for the Centers for Disease Control and Prevention to implement the National Neurological Conditions Surveillance System; $150 million for the Patient Centered Outcomes Research Institute (PCORI); $5 million for the Lifespan Respite Care Program; an increase over our recommended FY17 funding level of $13.067 billion for the SSAs administrative budget; and $364 million for the Agency for Healthcare Research and Quality (AHRQ). - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2018, support $2.8 billion for the FDA; the $500 million provided for targeted programs at the FDA by the 21st Century Cures Act; and an additional $1.35 billion in medical product user fees.
H.R. 2810/S.1519-National Defense Authorization Act (NDAA) of 2018, oppose amendment that threatens MS Research Program through the Congressionally Directed Medical Research Program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
-H.R. 1628, oppose the American Health Care Act and Better Care Reconciliation Act. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486, support passage to protect access to complex rehabilitative technology accessories. -H.R. 807/S.253 , Medicare Access to Rehabilitation Services Act, support passage. -H.R. 2556/S. 1016 Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017, support passage. -S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, support passage.
-H.R. 1628, oppose the American Health Care Act, Better Care Reconciliation Act and Obamacare Repeal Reconciliation Act. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories. -H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -H.R. 807/S.253 , Medicare Access to Rehabilitation Services Act, support passage. -H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage. -H.R. 2430/ S. 934, FDA Reauthorization Act of 2017, support passage. - H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2123/S. 925 Veterans E-Health and Telemedicine Support Act of 2017, support passage. -H.R. 2556/S. 1016 Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017, support passage. -S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, support passage. -S. 1028/H.R. 3759, RAISE Family Caregivers Act, support passage. -HR 2575, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
-H.R. 1628, oppose the American Health Care Act and Better Care Reconciliation Act. -H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 1361/S. 486, support passage to protect access to complex rehabilitative technology accessories. -H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program. -H.R. 807/S.253 , Medicare Access to Rehabilitation Services Act, support passage. -H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage. -H.R. 2430/ S. 934, FDA Reauthorization Act of 2017, support passage. - H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage. - H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2123/S. 925 Veterans E-Health and Telemedicine Support Act of 2017 -H.R. 2556/S. 1016 Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017 -S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 -S. 1374 Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 34, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 1516/S. 1013, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act. -H.R. 3229/S. 2196, support passage to protect access to complex rehabilitative technology accessories. -H.R. 3913, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
-H.R. 292/S. 849, support passage of the Advancing Research for Neurological Diseases Act. -H.R. 6, 21st Century Cures Act, support inclusion of H.R. 292/S. 849, support increased funding for the National Institutes of Health and support other provisions that speed the development of effective treatments for people with multiple sclerosis. -H.R. 4762/S. 2689, express concerns about patient safety and oppose inclusion of current version of bill in the Senate Innovations package
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE